Dr Mohan is a postdoctoral scientist with a research background in cardiovascular medicine and global mental health, particularly in low- and middle-income countries (LMICs). He joined Kings College London in February 2022 and is currently working at the Department of Child & Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience. He completed his doctoral degree (PhD) in Cardiovascular Medicine from University of Dundee, UK. In addition, he also has two MSc degrees (one in Bioinformatics and one in Biotechnology).

Dr Mohan's research interests takes a multi-disciplinary approach and are broadly focussed around cardiovascular medicine and psychiatry. These encompass studies to understand the pathophysiology of cardiovascular diseases in patients with psychotic disorders and development of treatment strategies for this group of patients.

Dr Mohan is an applied health researcher with expertise in conducting and managing clinical trials, Big Data studies and multicentre observational studies and global mental health programmes in LMICs. Over the last 10 years of his research career, he has been working on various national and international projects. He was the programme manager of the NIHR Global Health Group: Warwick-India-Canada (WIC) global mental health group. He was the Principal Investigator for the MRET-REMODEL trial that showed for the first time in a randomized controlled clinical trial that metformin can reduce left ventricular hypertrophy in high risk cardiovascular patients.

Research Interests

• Cardiovascular Diseases
• Severe Mental Illness
• Rare Diseases
• Global Health
• Metabolic Disorders
• Precision Medicine
• Neuropsychiatry

Research Groups

• Centre for Interventional Paediatric Psychopharmacology Research Team (CIPPRT)